A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy, Safety, and Pharmacokinetics of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy, Safety, and Pharmacokinetics of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Dec 2015

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Recro Pharma
  • Most Recent Events

    • 29 Oct 2014 Results published in a Recro Pharma media release.
    • 04 Sep 2014 Primary endpoint has not been met. (Summed pain intensity difference over the first 48 hours (SPID48))
    • 04 Sep 2014 Status changed from recruiting to discontinued, as reported in a Recro Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top